Official registry condition

Shock peptide trials

3 selected ClinicalTrials.gov records carrying the official condition label Shock. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

3 selected records.

Connected peptides

1 profiles.

Registry update years

2014–2026 in selected records.

Indication intelligence

Selected evidence landscape

Connected profiles1

Exact peptide identities attached to retained registry observations carrying this condition label.

Trial phases4

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses2

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 30 selected PubMed records and 14 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Shock unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT00379522

PeptideScanner retained ClinicalTrials.gov record NCT00379522 at 2026-11-15T22:08:31.832Z. Its registry update date was 2014-11-05, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
November 5, 2014
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01800877

PeptideScanner retained ClinicalTrials.gov record NCT01800877 at 2026-11-15T22:08:31.832Z. Its registry update date was 2019-03-12, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
March 12, 2019
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02118467

PeptideScanner retained ClinicalTrials.gov record NCT02118467 at 2026-11-15T22:08:31.832Z. Its registry update date was 2026-01-13, and PeptideScanner's reviewed identity mapping was vasopressin.

PeptideScanner change date
November 15, 2026
Cited source date
January 13, 2026
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →